[1]
T. Y. Mardining Raras, A. Fahrinda, Y. Yuliati, D. Y. Nurhidayati, H. Sujuti, and S. R. Prawiro, “IMMUNE RESPONSE UPON THE ADMINISTRATION OF RECOMBINANT PROTEIN ANTIBODIES Ag-38 KDa Mycobacterium tuberculosis AND RIFAMPICIN EX-VIVO”., Afr. J. Infect. Dis., vol. 16, no. 2, pp. 71–79, May 2022.